For example, in a single center cohort of patients undergoing SCT for GATA2 deficiency-related blood disorders, we found an increased risk of thrombotic and neurological complications, compared to patients with GATA2 wild-type MDS or ALL (147). The gene discussed is GATA2; the disease is acute lymphoblastic leukemia.